Canopy Growth Launches Cheaper 15g Medical Cannabis in Poland

A new strain of medical cannabis from Canopy Growth will be available in Polish pharmacies on March 6th, 2026. Patients will be able to purchase Blood Orange Kush in new, 15-gram packages. Most importantly, the manufacturer has announced a nearly 30 percent price reduction per gram.

A new product on the Polish market is Canopy Growth’s Blood Orange Kush. It boasts the highest THC concentration in the company’s current portfolio, boasting a whopping 29%, while CBD content remains minimal at less than 0.5%. Doctors will prescribe this medication under its official name: Cannabis flos, Canopy Growth THC 29%, CBD <0.5% .

Larger packaging means real savings

The high cost of treatment is one of the main challenges facing medical cannabis patients. Canopy Growth Polska has decided to address these challenges. The company is introducing, for the first time, a 15-gram package. Previously, all strains were sold in 5-gram packages.

The increased gram weight allowed the manufacturer to significantly reduce the drug’s price. Per gram, the new variant will be approximately 30 percent cheaper than standard offerings. This is a major step toward improving access to treatment.

Why Canopy Growth lowers the price

According to Canopy Growth, the lower price is the result of a major modernization of the entire plant. The company implemented new quality standards, streamlined production control, and improved logistics. This allows it to produce more and operate more efficiently.

Tomasz Witkowski, director of Canopy Growth Polska, emphasizes that the market has been waiting for such a solution for a long time. ” Today, we can offer high-quality medical cannabis at a more affordable price. This is a real step towards improving the availability of cannabis therapy in Poland, ” explains Witkowski.

When will the new drug be available in pharmacies?

Supply disruptions are a known problem in the Polish cannabis market. However, Canopy Growth is reassuring patients. The new production strategy aims to ensure complete therapy predictability and make the company more resilient to sudden market changes.

The Blood Orange Kush strain in new packaging will debut in pharmacies nationwide on March 6, 2026. The manufacturer guarantees that the increased scale of production will ensure stable availability of the drug for all those in need.

__

(Featured image by Elsa Olofsson via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in FaktyKonopne. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.